Enovis (ENOV) Equity Average (2011 - 2026)
Enovis (ENOV) reported Equity Average of $1.5 billion for Q2 2026, down 42.73% year-over-year from $2.6 billion in Q2 2025, and down 15.42% quarter-over-quarter from $1.8 billion in Q4 2025.
Enovis (ENOV) Equity Average (2011 - 2026) Analysis & Trends
Enovis (ENOV) has 16 years of Equity Average data on file, last reported at $1.5 billion in Q2 2026.
- Equity Average for Q2 2026 came in at $1.5 billion, down 42.73% year-over-year; the trailing twelve-month figure through Apr 2026 was $1.5 billion (down 42.73% YoY), and the FY2025 annual result was $2.0 billion, down 32.26% from the prior year.
- Equity Average fell to $1.5 billion in Q2 2026 per ENOV's latest filing, from $1.8 billion in the prior quarter.
- Over five years, Equity Average peaked at $4.7 billion in Q2 2022 and troughed at $1.5 billion in Q2 2026.
- A 5-year average of $3.1 billion and a median of $3.4 billion in 2024 frame the typical range for Equity Average.
- The sharpest annual moves came in 2022 and 2026: Equity Average increased 18.11% in 2022, then tumbled 42.73% in 2026.
- A 5-year view of Equity Average shows it stood at $3.4 billion in 2022, then gained by 0.06% to $3.4 billion in 2023, then dropped by 14.06% to $2.9 billion in 2024, then slumped by 40.48% to $1.8 billion in 2025, then retreated by 15.42% to $1.5 billion in 2026.
- Business Quant data shows ENOV's Equity Average at $1.5 billion in Q2 2026, $1.8 billion in Q4 2025, and $2.3 billion in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 52.42 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 22.70 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 49.03 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 25.17 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 10.33 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 13.05 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 2.85 Bn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 10.53 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 7.18 Bn |
| 10 | Enovis | 1.26 Bn | 1.23 Bn | 365.49 Mn | 1.48 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 3, 2026 | 1.48 Bn |
| Dec 31, 2025 | 1.76 Bn |
| Oct 3, 2025 | 2.30 Bn |
| Jul 4, 2025 | 2.60 Bn |
| Apr 4, 2025 | 2.59 Bn |
| Dec 31, 2024 | 2.95 Bn |
| Sep 27, 2024 | 3.31 Bn |
| Jun 28, 2024 | 3.30 Bn |
| Mar 29, 2024 | 3.37 Bn |
| Dec 31, 2023 | 3.43 Bn |
| Sep 29, 2023 | 3.45 Bn |
| Jun 30, 2023 | 3.45 Bn |
| Mar 31, 2023 | 3.45 Bn |
| Dec 31, 2022 | 3.43 Bn |
| Sep 30, 2022 | 3.45 Bn |
| Jul 1, 2022 | 4.07 Bn |
| Apr 1, 2022 | 4.65 Bn |
| Dec 31, 2021 | 4.65 Bn |
| Oct 1, 2021 | 4.49 Bn |
| Jul 2, 2021 | 4.32 Bn |